T15	Exp 28 50	the interleukin-2 gene
T16	Exp 112 129	the immune system
T17	Exp 130 150	the first activation
T18	Exp 197 208	the shaping
T19	Exp 212 256	the peripheral T cell specificity repertoire
T20	Exp 373 377	that
T21	Exp 295 312	the present study
T22	Exp 326 343	the interleukin-2
T23	Exp 554 592	the purine-rich IL-2 promoter elements
T24	Exp 643 649	either
T25	Exp 643 658	either in vitro
T26	Exp 1154 1156	it
T27	Exp 809 833	Their IL-2 transcription
T28	Exp 1004 1019	its cytoplasmic
T29	Exp 867 881	the transition
T30	Exp 1067 1080	the activator
T31	Exp 1095 1108	the cytoplasm
T32	Exp 1217 1228	the nucleus
T33	Exp 887 992	inactive to active functional state of a positive transcription factor binding to these promoter elements
T34	Exp 1236 1250	the regulation
T35	Exp 1254 1262	the gene
T36	Exp 1274 1311	the main T cell growth factor changes
T37	Exp 1331 1350	the first encounter
T38	Exp 1376 1378	It
T39	Exp 1394 1398	that
T40	Exp 1399 1411	the presence
T41	Exp 1441 1483	the more stringent activation requirements
T42	SPAN 717 752	CD4+ T (memory) clones, or CD4+CD45
R5	Coref Anaphora:T27 Antecedent:T42
R6	Coref Anaphora:T28 Antecedent:T29
R7	Coref Anaphora:T26 Antecedent:T30
R8	Coref Anaphora:T35 Antecedent:T11
T1	Protein 32 45	interleukin-2
T2	Protein 330 343	interleukin-2
T3	Protein 345 349	IL-2
T4	Protein 417 420	CD4
T5	Protein 437 440	CD4
T6	Protein 441 445	CD45
T7	Protein 467 471	IL-2
T8	Protein 570 574	IL-2
T9	Protein 717 720	CD4
T10	Protein 744 747	CD4
T11	Protein 748 752	CD45
T12	Protein 815 819	IL-2
T13	Protein 1493 1496	CD4
